Circulating adipokines data associated with insulin secretagogue use in breast cancer patients
Oral drugs stimulating endogenous insulin production (insulin secretagogues) may have detrimental effects on breast cancer outcomes. The data presented shows the relationship between pre-existing insulin secretagogues use, adipokine profiles at the time of breast cancer (BC) diagnosis and subsequent...
Main Authors: | Zachary A.P. Wintrob, Jeffrey P. Hammel, George K. Nimako, Zahra S. Fayazi, Dan P. Gaile, Alan Forrest, Alice C. Ceacareanu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-02-01
|
Series: | Data in Brief |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S235234091630720X |
Similar Items
-
Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01) -
Insulin secretagogue use and circulating inflammatory C–C chemokine levels in breast cancer patients
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01) -
Dataset on granulopoiesis- and lymphopoiesis-stimulating cytokine levels in insulin secretagogue users with incident breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01) -
TH1 and TH2 cytokine data in insulin secretagogues users newly diagnosed with breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01) -
Insulin use, hormone receptor status and hematopoietic cytokines׳ circulation in women with diabetes mellitus and breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01)